Professor Robert Huddart is a Consultant Clinical Oncologist. He qualified in Medicine in 1986 from the University of London and now specialises in the management of testicular, bladder and prostate cancer.
He is strongly committed to research which currently includes studies into the genetics and late effects of testicular cancer and the management of all testicular cancer with a focus on improving outcomes in high-risk disease and minimising toxicity in low risk disease. Professor Huddart's other areas of interest include the management of bladder cancer with neoadjuvant chemotherapy and improving conservative treatment for bladder cancer. He is also researching the technical development of radiotherapy and imaging.